Unknown PHASE4 INTERVENTIONAL 2-arm NCT05342376

Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering.

Role of Dexmeditomidine HCL for Prevention of Shivering in Obstetrical Spinal Anesthesia, a Randomized Controlled Double Blind Parallel Study.

Sponsor: Rehman Medical Institute - RMI

Conditions Cesarean Delivery Postoperative Shivering

Interventions Dexmedetomidine Hydrochloride Normal Saline

Updated 5 times since 2022 Last updated: May 5, 2022 Started: Feb 1, 2022 Primary completion: Jun 30, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cesarean Delivery and Postoperative Shivering and is currently ongoing. Rehman Medical Institute - RMI leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jun 2024 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2022 — Jun 2024 [monthly]

Recruiting PHASE4
May 2022 — Jun 2022 [monthly]

Recruiting PHASE4

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rehman Medical Institute - RMI

Data source: Rehman Medical Institute - RMI

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan